News Releases - CSL
WEB5 days ago — Recent News Releases. For investor-related news, see our ASX releases here. Basic Search. Head-to-head data, presented at OPTIONS XII for the Control of Influenza Conference, demonstrates advantage of sa-mRNA over conventional mRNA in duration of immune response; Results highlight CSL...
News Releases - CSL
WEBApr 17, 2024 — Sep 13, 2024. Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma.
Global Newsroom | CSL
WEBCSL. Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination.
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply
WEB11 hours ago — The latest award includes $37.9 million for CSL, $23.4 million for Sanofi and $10.5 million for GSK. It would more than double the country's supply of shots targeting bird flu, raising the country ...
CSL Seqirus, a Global Leader in Pandemic Preparedness, …
WEB7 hours ago — CSL (ASX:CSL) (USOTC:CSLLY) is a global biotechnology company with a dynamic portfolio of medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza ...
Financial Results and Information | Global Biotechnology Company | CSL
WEBWe have announced our 2024 Full Year Financial Results for the period ending June 30 th 2024. Please click here to view the full information. A recording of the 2024 Full Year Results Announcement Webcast can be viewed here. View our 2024 Annual report.
Global Biotechnology Company | CSL
WEBCSL Behring is pleased to announce applications for the Prof Heimburger Award 2025 are now open for researchers in the areas of acquired and inherited bleeding disorders. Five grants of €25,000 are given each year to early-career researchers from all over the world.
Australia's CSL falls on weaker-than-expected annual profit forecast
WEBAug 13 (Reuters) - Shares of CSL Ltd (CSL.AX) fell more than 3% on Tuesday after the Australian biotech firm forecast an annual profit that was higher than a year earlier but below market...
Glenn Fishwick Joins CSL Group as Chief Technology Officer to …
WEB3 days ago — News provided by. CSL Group Oct 01, 2024, 05:00 ET. Share this article. Share to X. ... At CSL Group, Glenn will lead the company's technology strategy and development, focusing on enhancing its ...
Annual Reports | Global Biotechnology Company | CSL - CSL Limited
WEBCSL's latest and archived Annual Reports. CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Together they help ensure people everywhere get the treatments they need.